Infuse lawsuit: Judge orders Medtronic to produce safety data on bone growth protein
A federal judge in Minnesota orders Medtronic to produce documents detailing the safety profile of its controversial Infuse bone growth protein in a shareholders' lawsuit against the world's largest pure-play device maker.
A federal judge ordered Medtronic Inc. (NYSE:MDT) to produce documents detailing the safety record of its controversial Infuse bone growth protein.
The shareholders' lawsuit accuses the firm of artificially inflating its stock price with an off-label promotion scheme for a bone ...
